Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors

Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors

Zika virus (ZIKV) emerged on a global scale and no licensed vaccine ensures long-lasting anti-ZIKV immunity. Here we report the design and comparative evaluation of four replication-deficient chimpanzee adenoviral (ChAdOx1) ZIKV vaccine candidates comprising the addition or deletion of precursor mem...

Bibliografiset tiedot
Päätekijät:	López-Camacho, C, Abbink, P, Larocca, R, Dejnirattisai, W, Boyd, M, Badamchi-Zadeh, A, Wallace, Z, Doig, J, Velazquez, R, Neto, R, Coelho, D, Kim, Y, Donald, C, Owsianka, A, De Lorenzo, G, Kohl, A, Gilbert, S, Dorrell, L, Mongkolsapaya, J, Patel, A, Screaton, G, Barouch, D, Hill, A, Reyes-Sandoval, A
Aineistotyyppi:	Journal article
Julkaistu:	Nature Publishing Group 2018

Samankaltaisia teoksia

Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors
Tekijä: César López-Camacho, et al.
Julkaistu: (2018-06-01)

Therapeutic and protective efficacy of a dengue antibody against Zika infection in rhesus monkeys
Tekijä: Abbink, P, et al.
Julkaistu: (2018)

Immunogenicity and efficacy of Zika virus envelope domain III in DNA, protein, and ChAdOx1 adenoviral-vectored vaccines
Tekijä: López-Camacho, C, et al.
Julkaistu: (2020)

Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines
Tekijä: César López-Camacho, et al.
Julkaistu: (2020-06-01)

Immunogenicity and cross-reactivity of rhesus adenoviral vectors
Tekijä: Iampietro, M, et al.
Julkaistu: (2018)

The immunology of Zika virus
Tekijä: Culshaw, A, et al.
Julkaistu: (2018)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
Tekijä: Ewer (nee Russell), K, et al.
Julkaistu: (2017)

Evolution of neurovirulent Zika virus
Tekijä: Screaton, G, et al.
Julkaistu: (2017)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
Tekijä: Katie Ewer, et al.
Julkaistu: (2017-12-01)

Development of novel vaccine vectors: Chimpanzee adenoviral vectors
Tekijä: Jingao Guo, et al.
Julkaistu: (2018-07-01)

Assessment of immunogenicity and efficacy of a Zika vaccine using modified vaccinia Ankara virus as carriers
Tekijä: López-Camacho, C, et al.
Julkaistu: (2019)

Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge.
Tekijä: Freek Cox, et al.
Julkaistu: (2018-01-01)

A novel vaccine strategy employing serologically different chimpanzee adenoviral vectors for the prevention of HIV-1 and HCV coinfection
Tekijä: Hartnell, F, et al.
Julkaistu: (2019)

Chimpanzee adenoviral vectors as vaccines – challenges to move the technology into the fast lane
Tekijä: Alessandra Vitelli, et al.
Julkaistu: (2017-12-01)

The immunology of Zika Virus [version 1; referees: 2 approved]
Tekijä: Abigail Culshaw, et al.
Julkaistu: (2018-02-01)

Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product.
Tekijä: Xiang, Z, et al.
Julkaistu: (2002)

A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection
Tekijä: Felicity Hartnell, et al.
Julkaistu: (2019-01-01)

Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers
Tekijä: César López-Camacho, et al.
Julkaistu: (2019-11-01)

A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
Tekijä: Swadling, L, et al.
Julkaistu: (2014)

The epitope arrangement on flavivirus particles contributes to Mab C10’s extraordinary neutralization breadth across Zika and dengue viruses
Tekijä: Sharma, A, et al.
Julkaistu: (2021)

Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection
Tekijä: Fernandez, E, et al.
Julkaistu: (2017)

A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection
Tekijä: Campos, JL, et al.
Julkaistu: (2019)

Quantifying Adenoviral Titers by Spectrophotometry
Tekijä: S.J. O’Carroll, et al.
Julkaistu: (2000-03-01)

Role of Capsid anchor in the morphogenesis of Zika virus
Tekijä: Rana, J, et al.
Julkaistu: (2018)

Longitudinal analysis of antibody cross-neutralization following Zika and dengue virus infection in Asia and the Americas
Tekijä: Montoya, M, et al.
Julkaistu: (2018)

Combined HDAC and BET inhibition enhances melanoma vaccine immunogenicity and efficacy
Tekijä: Badamchi-Zadeh, A, et al.
Julkaistu: (2018)

A novel chimpanzee adenoviral vectored HBV vaccine, encoding multiple HBV antigens with a shark invariant chain adjuvant, for use in HBV immunotherapy
Tekijä: Chinnakannan, S, et al.
Julkaistu: (2018)

Dengue and Zika Virus Cross-Reactive Human Monoclonal Antibodies Protect against Spondweni Virus Infection and Pathogenesis in Mice
Tekijä: Vanessa Salazar, et al.
Julkaistu: (2019-02-01)

Dengue and Zika virus cross-reactive human monoclonal antibodies protect against Spondweni virus infection and pathogenesis in mice
Tekijä: Salazar, V, et al.
Julkaistu: (2019)

Adenovirus serotype 5 vaccine vectors trigger IL-27-dependent inhibitory CD4(+) T cell responses that impair CD8(+) T cell function
Tekijä: Larocca, R, et al.
Julkaistu: (2016)

Immediate dysfunction of vaccine-elicited CD8+ T cells primed in the absence of CD4+ T cells
Tekijä: Provine, N, et al.
Julkaistu: (2016)

Chimpanzee adenoviral vector prime-boost regimen elicits potent immune responses against Ebola virus in mice and rhesus macaques
Tekijä: Xi Yang, et al.
Julkaistu: (2019-01-01)

Engineering Adenoviral Vectors with Improved GBM Selectivity
Tekijä: Emily A. Bates, et al.
Julkaistu: (2023-04-01)

Which dengue vaccine approach is the most promising, and should we be concerned about enhanced disease after vaccination? The challenges of a dengue vaccine
Tekijä: Screaton, G, et al.
Julkaistu: (2018)

Potent neutralizing human monoclonal antibodies preferentially target mature dengue virus particles: implication for novel strategy of dengue vaccine
Tekijä: Tsai, W, et al.
Julkaistu: (2018)

The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors; A Novel Therapeutic Vaccine Strategy against HBV
Tekijä: Senthil K. Chinnakannan, et al.
Julkaistu: (2020-04-01)

Structural analysis of a dengue cross-reactive antibody complexed with envelope domain III reveals the molecular basis of cross-reactivity.
Tekijä: Midgley, C, et al.
Julkaistu: (2012)

Antibodies and tuberculosis
Tekijä: Jacobs, A, et al.
Julkaistu: (2016)

Guillain-Barré syndrome following Zika virus infection is associated with a diverse spectrum of peripheral nerve reactive antibodies
Tekijä: Davies, AJ, et al.
Julkaistu: (2022)

Adenoviral Keratoconjunctivitis
Tekijä: Alexander Bialasiewicz
Julkaistu: (2007-04-01)